Timothy J Kennedy
Overview
Explore the profile of Timothy J Kennedy including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
37
Citations
320
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Ajay P, Mavani P, Sok C, Goyal S, Switchenko J, Gillespie T, et al.
J Surg Oncol
. 2024 Aug;
130(5):1078-1091.
PMID: 39190495
Background: To determine the optimal multimodal treatment strategy between perioperative chemotherapy (PEC), postoperative chemoradiation therapy (POCR), and postoperative chemotherapy (POC) in resected gastric cancer (GC) patients based on nodal status....
2.
Ko T, Laraia K, Alexander H, Ecker B, Grandhi M, Kennedy T, et al.
Surgery
. 2024 Jul;
176(3):626-632.
PMID: 38972769
Background: The incidence of early-onset colorectal cancer has increased markedly over the past decade. Although established for older adults, there are limited data on socioeconomic and racial disparities in screening,...
3.
Tsagkalidis V, Choe J, Beninato T, Eskander M, Grandhi M, In H, et al.
Ann Surg Oncol
. 2024 Apr;
31(7):4203-4212.
PMID: 38594579
Background: Mucinous appendiceal adenocarcinomas (MAA) and non-mucinous appendiceal adenocarcinomas (NMAA) demonstrate differences in rates and patterns of recurrence, which may inform the appropriate extent of surgical resection (i.e., appendectomy versus...
4.
Allen W, Greendyk J, Alexander H, Beninato T, Eskander M, Grandhi M, et al.
Surgery
. 2024 Feb;
175(5):1402-1407.
PMID: 38423892
Background: Racial and ethnic disparities have been observed in the multidisciplinary management of pancreatic ductal adenocarcinoma. Intraductal papillary mucinous neoplasm is the most common identifiable precursor to pancreatic ductal adenocarcinoma,...
5.
Vail E, Choubey A, Alexander H, August D, Berry A, Boland P, et al.
Cancer Med
. 2024 Jan;
13(1):e6884.
PMID: 38186327
Background: Several cytotoxic chemotherapies have demonstrated efficacy in improving recurrence-free survival (RFS) following resection of Stage II-IV colorectal cancer (CRC). However, the temporal dynamics of response to such adjuvant therapy...
6.
Greendyk J, Allen W, Alexander H, Beninato T, Eskander M, Grandhi M, et al.
Biomedicines
. 2023 Nov;
11(11).
PMID: 38002058
Several molecular biomarkers have been identified to guide induction treatment selection for localized pancreatic ductal adenocarcinoma (PDAC). alterations and low expression/modified "Moffitt" basal-like phenotype have each been associated with inferior...
7.
Ajay P, Rajamanickam R, Rhee K, NeMoyer R, Goyal S, Switchenko J, et al.
Surg Endosc
. 2023 Nov;
38(1):136-147.
PMID: 37935921
Background: Multimodal treatment strategy including perioperative chemotherapy (PEC), postoperative chemoradiation therapy (POCR), and postoperative chemotherapy (POC) has been accepted as the standard of care in gastric cancer (GC). The ideal...
8.
Davis C, Choubey A, Langan R, Grandhi M, Kennedy T, August D, et al.
HPB (Oxford)
. 2023 Oct;
26(1):109-116.
PMID: 37805363
Background: Multiple guidelines on the management of intraductal papillary mucinous neoplasm (IPMN) have been published over the past decade. However, practice data are lacking. This study aims to determine whether...
9.
Ajay P, Sok C, Goyal S, Switchenko J, Maegawa F, Gillespie T, et al.
J Surg Oncol
. 2023 Apr;
128(2):242-253.
PMID: 37114465
Background: Patients with resectable noncardia gastric cancer may be subjected to perioperative chemotherapy (PEC), postoperative chemoradiation (POCR), or postoperative chemotherapy (POC). We analyzed these treatment strategies to determine optimal therapy...
10.
Ajay P, NeMoyer R, Goyal S, Switchenko J, Lin Y, Jabbour S, et al.
J Surg Oncol
. 2023 Apr;
128(2):231-241.
PMID: 37036147
Background: Multimodal treatment strategies with surgery as its centerpiece have been accepted as the standard of care in nonmetastatic cardia gastric cancer (CGC). There remains a lack of consensus regarding...